1. |
Claes L, Del-Favero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet, 2001, 68(2):1327-1332.
|
2. |
Escayg A, MacDonal B, Meisler M, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet, 2000, 24(6):343-345.
|
3. |
Harkin LA, Mc Mahon JM, Iona X, et al. The spectrum of SCN1Arelated infantile epileptic encephalopathies. Brain, 2007, 130(10):843-852.
|
4. |
Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain, 1997, 120(8):479-490.
|
5. |
Zuberi SM, Brunklaus A, Birch R, et al. Genotype-phenotype associations in SCN1A related epilepsies. Neurology, 2011, 76(7):594-600.
|
6. |
Dravet C, Bureau M, Oguni H, et al. Severe myoclonic epilepsy in infancy (Dravet syndrome). In Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P (Eds) Epileptic syndromes in infancy, childhood and adolescence. London:John Libbey, 2005:89-113.
|
7. |
Brunklaus A, Ellis R, Reavey E, et al. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain, 2012, 135(12):2329-2336.
|
8. |
Ragona F, Granata T, Bernardina BD, et al. Cognitive development in Dravet syndrome:a retrospective, multicenter study of 26 patients. Epilepsia, 2011, 52(6):386-392.
|
9. |
Nabbout R, Chemaly N, Chipaux M, et al. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy. Orphanet J Rare Dis, 2013, 8(2):176.
|
10. |
Chieffo D, Battaglia D, Lettori D, et al. Neuropsychological development in children with Dravet syndrome. Epilepsy Res, 2011, 95(8):86-93.
|
11. |
Depienne C, Trouillard O, Saint-Martin C, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome:analysis of 333 patients. J Med Genet, 2009, 46(5):183-191.
|
12. |
Dravet C. How Dravet syndrome became a model for studying childhood genetic epilepsies. Brain, 2012, 135(10):2309-2311.
|
13. |
Wolff M, Cass-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome):natural history and neuropsychological findings. Epilepsia, 2006, 47(8):45-48.
|
14. |
Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:report of the ILAE Task Force on Classification and Terminology. Epilepsia, 2001, 42(10):796-803.
|
15. |
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies:report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia, 2010, 51(10):676-685.
|
16. |
Ogiwara I, Miyamoto H, Morita N, et al. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons:a circuit basis for epileptic seizures in mice carrying anScn1a gene mutation. J Neurosci, 2007, 27(3):5903-5914.
|
17. |
Yu FH, Mantegazza M, Westenbroek RE, et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci, 2006, 9(1):1142-1149.
|
18. |
Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev, 2005, 57(10):397-409.
|
19. |
Skluzacek JV, Watts KP, Parsy O, et al. Dravet syndrome and parent associations:the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia, 2011, 52(8):95-101.
|
20. |
Kalume F, Westenbroek RE, Cheah CS, et al. Sudden unexpected death in a mouse model of Dravet syndrome. J Clin Invest, 2013, 123(9):1798-1808.
|
21. |
Auerbach DS, Jones J, Clawson BC, et al. Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome. PLo S ONE, 2013, 8(10):e77843.
|
22. |
Han S, Tai C, Westenbroek RE, et al. Autistic-like behaviour in Scn1a+/mice and rescue by enhanced GABA-mediated neurotransmission. Nature, 2012, 489(20):385-390.
|
23. |
Brunklaus A, Dorris L, Zuberi SM. Comorbidities and predictors of health-related quality of life in Dravet syndrome. Epilepsia, 2011, 52(11):1476-1482.
|
24. |
Bender AC, Natola H, Ndong C, et al. Focal Scn1a knockdown induces cognitive impairment without seizures. Neurobiol Dis, 2013, 54(5):297-307.
|
25. |
Liu Y, Lopez-Santiago LF, Yuan Y, et al. Dravet syndrome patientderived neurons suggest a novel epilepsy mechanism. Ann Neurol, 2013, 74(2):128-139.
|
26. |
Cheah CS, Westenbroek RE, Roden WH, et al. Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. Channels, 2013, 7(3):468-472.
|
27. |
Biella G, Di Febo F, Goffredo D, et al. Differentiating embryonic stem derived neural stem cells show a maturation-dependent pattern of voltage-gated sodium current expression and graded action potentials. Neuroscience, 2007, 149(3):38-52.
|
28. |
Stafstrom CE. Severe epilepsy syndromes of early childhood:the link between genetics and pathophysiology with a focus on SCN1A mutations. J Child Neurol, 2009, 24(Suppl.2):15-23.
|
29. |
Heron SE, Crossland KM, Andermann E, et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet, 2002, 360(12):851-852.
|
30. |
Liao Y, Deprez L, Maljevic S, et al. Molecular correlates of age dependent seizures in an inherited neonatal-infantile epilepsy. Brain, 2010, 133(6):1403-1414.
|
31. |
Nakamura K, Kato M, Osaka H, et al. Clinical spectrum ofSCN2A mutations expanding to Ohtahara syndrome. Neurology, 2013, 81(3):992-998.
|
32. |
Ogiwara I, Ito K, Sawaishi Y, et al. De novo mutations of voltagegated sodium channel alpha 2 geneSCN2A in intractable epilepsies. Neurology, 2009, 73(10):1046-1053.
|
33. |
Hawkins NA, Martin MS, Frankel WN, et al. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus. Neurobiol Dis, 2011, 41(8):655-660.
|
34. |
Martin MS, Tang B, Papale LA, et al. The voltage-gated sodium channelScn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Hum Mol Genet, 2007, 16(6):2892-2899.
|
35. |
Catarino CB, Liu JYW, Liagkouras I, et al. Dravet syndrome as epileptic encephalopathy:evidence from long-term course and neuropathology. Brain, 2011, 134(3):2982-3010.
|
36. |
Kanai K, Yoshida S, Hirose S, et al. Physicochemical property changes of amino acid residues that accompany missense mutations inSCN1A affect epilepsy phenotype severity. J Med Genet, 2009, 46(3):671-679.
|
37. |
Brunklaus A, Dorris L, Ellis R, et al. The clinical utility of anSCN1A genetic diagnosis in infantile-onset epilepsy. Dev Med Child Neurol, 2013, 55(2):154-161.
|
38. |
Hirose S, Scheffer IE, Marini C, et al.SCN1A testing for epilepsy:application in clinical practice. Epilepsia, 2013, 54(6):946-952.
|
39. |
Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy:a randomised placebo-controlled syndrome-dedicated trial. Lancet, 2000, 356(7):1638-1642.
|
40. |
Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia, 1998, 39(11):508-512.
|
41. |
Grantham R. Amino acid difference formula to help explain protein evolution. Science, 1974, 185(7):862-864.
|
42. |
Sim NL, Kumar P, Hu J, et al. SIFT web server:predicting effects of amino acid substitutions on proteins. Nucleic Acids Res, 2012, 40(9):452-457.
|
43. |
Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs:server and survey. Nucleic Acids Res, 2002, 3(6):3894-3900.
|
44. |
Catterall WA. From ionic currents to molecular mechanisms:the structure and function of voltage-gated sodium channels. Neuron, 2000, 26(8):13-25.
|
45. |
Ogiwara I, Nakayama T, Yamagata T, et al. A homozygous mutation of voltage-gated sodium channel beta subunit type 1 gene SCN1B in a patient with Dravet syndrome. Epilepsia, 2012, 53(12):200-203.
|
46. |
Patino GA, Claes LR, Lopez-Santiago LF, et al. A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci, 2009, 29(9):10764-10778.
|
47. |
Ottman R, Hirose S, Jain S, et al. Genetic testing in the epilepsies:report of the ILAE Genetics Commission. Epilepsia, 2010, 51(7):655-670.
|